Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

BOSTON SCIENTIFIC CORP Director's Dealing 2021

Aug 11, 2021

29821_dirs_2021-08-11_6af809f6-1c54-4f30-95a2-3edad2e894f2.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: BOSTON SCIENTIFIC CORP (BSX)
CIK: 0000885725
Period of Report: 2021-08-10

Reporting Person: Thepaut Eric Francis Yves (EVP & Pres, Eur, Mid-East, Afr)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2021-08-10 Common Stock M 20000.0000 $13.0800 Acquired 86128.9900 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2021-08-10 Stock Option (Right to Buy) $13.0800 M 20000.0000 Disposed 2024-02-24 Common Stock (20000.0000) Direct

Footnotes

F1: Grant to the reporting person of an option to purchase 20,000 shares of common stock vesting in four equal annual installments beginning on February 24, 2015, the first anniversary of the date of grant.